valylvaline has been researched along with ganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrahari, V; Mitra, AK; Pal, D; Shah, SJ; Wang, Z; Yang, X | 1 |
| Mitra, AK; Pal, D; Ray, A; Shah, SJ; Sheng, Y; Trinh, HM; Yang, X | 1 |
2 other study(ies) available for valylvaline and ganciclovir
| Article | Year |
|---|---|
Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Topics: Administration, Ophthalmic; Delayed-Action Preparations; Dipeptides; Drug Delivery Systems; Emulsions; Eye Diseases; Ganciclovir; Gels; Lactic Acid; Microspheres; Nanoparticles; Particle Size; Polyesters; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prodrugs | 2016 |
Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.
Topics: Antiviral Agents; Cornea; Dipeptides; Emulsions; Epithelial Cells; Ganciclovir; Humans; Nanoparticles; Prodrugs | 2016 |